1. Home
  2. PRA vs VCEL Comparison

PRA vs VCEL Comparison

Compare PRA & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProAssurance Corporation

PRA

ProAssurance Corporation

HOLD

Current Price

$24.57

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$29.29

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRA
VCEL
Founded
1976
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.7B
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
PRA
VCEL
Price
$24.57
$29.29
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$25.00
$58.50
AVG Volume (30 Days)
626.4K
610.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
0.99
0.32
Revenue
$1,098,028,000.00
$276,259,000.00
Revenue This Year
N/A
$19.10
Revenue Next Year
N/A
$17.95
P/E Ratio
$24.98
$96.31
Revenue Growth
N/A
16.45
52 Week Low
$22.72
$29.24
52 Week High
$24.85
$45.97

Technical Indicators

Market Signals
Indicator
PRA
VCEL
Relative Strength Index (RSI) 50.74 30.35
Support Level $23.88 N/A
Resistance Level $24.64 $38.48
Average True Range (ATR) 0.13 1.52
MACD -0.00 -0.18
Stochastic Oscillator 34.88 9.09

Price Performance

Historical Comparison
PRA
VCEL

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: